Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Danaher Corp DHR

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the... see more

Recent & Breaking News (NYSE:DHR)

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Danaher Corporation (DHR) Investigation

Accesswire November 16, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Danaher Corporation (DHR) Investigation

Accesswire November 15, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Danaher Corporation (DHR) Investigation

Accesswire November 14, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Danaher Corporation (DHR) Investigation

Accesswire November 12, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Danaher Corporation (DHR) Investigation

Accesswire November 10, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Danaher Corporation (DHR) Investigation

Accesswire November 9, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Danaher Corporation (DHR) Investigation

Accesswire November 8, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Danaher Corporation (DHR) Investigation

Accesswire November 7, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Danaher Corporation (DHR) Investigation

Accesswire November 6, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Danaher Corporation (DHR) Investigation

Accesswire November 5, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Danaher Corporation (DHR) Investigation

Accesswire November 3, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Danaher Corporation (DHR) Investigation

Accesswire November 2, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Danaher Corporation (DHR) Investigation

Accesswire November 1, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Danaher Corporation (DHR) Investigation

Accesswire October 31, 2023

Danaher appoints Christopher Riley to Executive Vice President for Biotechnology

PR Newswire October 31, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Danaher Corporation (DHR) Investigation

Accesswire October 30, 2023

Danaher Reports Third Quarter 2023 Results

PR Newswire October 24, 2023

Danaher Corporation Completes Separation of Veralto Corporation

PR Newswire September 30, 2023

Veralto Set to Join S&P 500; Vestis to Join S&P MidCap 400; Others to Join S&P SmallCap 600

PR Newswire September 28, 2023

Danaher Schedules Third Quarter 2023 Earnings Conference Call

PR Newswire September 26, 2023